-2%
HexPark contains Trihexyphenidyl, a muscarinic acetylcholine receptor antagonist, which primarily targets M1 receptors in the brain.
This medication works by:
- Inhibiting the parasympathetic nervous system, thereby reducing involuntary muscle movements.
- Relaxing smooth muscles, helps in relieving muscle stiffness and tremors.
- Enhancing dopamine release in the brain’s striatum, indirectly improving motor functions.
Although the exact mechanism of action is not fully understood, Trihexyphenidyl is proven to be effective in Parkinson’s disease and drug-induced movement disorders.
HexPark Tablet is primarily prescribed as an adjunctive treatment for various forms of parkinsonism, including:
- Postencephalitic Parkinsonism (caused by inflammation of the brain)
- Arteriosclerotic Parkinsonism (associated with narrowing of blood vessels)
- Idiopathic Parkinsonism (of unknown origin)
Additionally, HexPark is often used alongside levodopa therapy to enhance treatment effectiveness.
Furthermore, this medication is beneficial in managing extrapyramidal disorders—movement-related side effects caused by central nervous system (CNS) drugs, such as:
- Dibenzoxazepines
- Phenothiazines
- Thioxanthenes
- Butyrophenones
These drug-induced movement disorders can include tremors, muscle stiffness, and involuntary movements.
Important Note: Always take HexPark under the supervision of a registered medical professional